Company Perspective Therapeutics, Inc.

Equities

CATX

US46489V1044

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:24:49 2024-03-28 pm EDT 5-day change 1st Jan Change
1.185 USD -1.25% Intraday chart for Perspective Therapeutics, Inc. -11.57% +194.78%

Business Summary

Perspective Therapeutics, Inc. is a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents. The Company is focused on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies, so its targeted medical doses are delivered directly to the tumor site. The Company’s core product is its Cesium-131 sealed source brachytherapy seed. These seeds can be inserted individually or in combination into various locations in the body. The Company also sells seeds in strands to keep them from individually moving. The Company’s segments are Brachytherapy and Drug Operations. Brachytherapy includes sales and manufacturing of Cesium-131 brachytherapy seeds, including research and development of new applications for the seeds. Drug Operations includes research and development and clinical operations related to the use of Lead-203 and Lead-212 as a diagnostic and a therapeutic drug.

Number of employees: 91

Sales per Business

USD in Million2021Weight2022Weight Delta
Prostate Brachytheraphy
74.7 %
8 77.8 % 8 74.7 % +3.02%
Other
25.3 %
2 22.2 % 3 25.3 % +22.70%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
10 100.0 % 11 100.0 % +7.43%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 585,322,904 404,560,568 ( 69.12 %) 0 69.12 %

Shareholders

NameEquities%Valuation
116,773,394 19.90 % 105 M $
Asv – Viewpoint LLC
4.590 %
26,933,868 4.590 % 24 M $
Coleman 2022 Exempt Family Trust
2.811 %
16,497,116 2.811 % 15 M $
15,734,658 2.681 % 14 M $
15,734,658 2.681 % 14 M $
Vanguard Global Advisers LLC
2.252 %
13,213,750 2.252 % 12 M $
Baker Bros. Advisors LP
1.302 %
7,639,703 1.302 % 7 M $
BlackRock Institutional Trust Co. NA
0.7734 %
4,538,389 0.7734 % 4 M $
Geode Capital Management LLC
0.4289 %
2,516,649 0.4289 % 2 M $
Ghost Tree Capital LLC
0.2727 %
1,600,000 0.2727 % 1 M $

Company contact information

Perspective Therapeutics, Inc.

2401 Elliott Avenue Suite 320

98121, Seattle

+

http://perspectivetherapeutics.com
address Perspective Therapeutics, Inc.(CATX)